Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1989 Mar;33(3):316–321. doi: 10.1128/aac.33.3.316

Pharmacokinetics of intramuscular amopyroquin in healthy subjects and determination of a therapeutic regimen for Plasmodium falciparum malaria.

F Verdier 1, E Pussard 1, F Clavier 1, J Le Bras 1, C Gaudebout 1
PMCID: PMC171485  PMID: 2658783

Abstract

The disposition of amopyroquin was investigated in 10 healthy volunteers after a single 2-mg/kg (body weight) intramuscular dose of amopyroquin base. The major form of the drug in plasma and in whole blood was nonmetabolized amopyroquin, and only very low levels of its primary amine derivative were detected. After a rapid absorption phase (15 min), levels in plasma declined, following a tri-exponential model with a terminal elimination half-life of 129.6 +/- 92.5 h. The apparent volume of distribution (V/F) and the systemic clearance (CL/F) were 238 +/- 75 liters/kg and 2,063 +/- 1,159 ml/min, respectively. The renal clearance, calculated by using urine excreted during the first 48 h, was 119 +/- 99 ml/min and represented about 6% of the systemic clearance. About 1.2 and 0.2% of the amopyroquin dose was excreted in the urine during the first 48 h as nonmetabolized amopyroquin and its primary amine metabolite, respectively. Twenty-two Plasmodium falciparum malaria patients were studied after treatment with one of the following regimens of intramuscularly injected amopyroquin base: 3 mg/kg (body weight), 6 mg/kg, or 6 mg/kg followed by 3 mg/kg 24 h later. Parasitemia was cleared at day 7 in one of six, four of seven, and seven of nine patients, respectively. On the basis of this study, a regimen of 12 mg/kg (body weight) administered in two or three injections is suggested.

Full text

PDF
316

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aderounmu A. F., Salako L. A., Lindström B., Walker O., Ekman L. Comparison of the pharmacokinetics of chloroquine after single intravenous and intramuscular administration in healthy Africans. Br J Clin Pharmacol. 1986 Nov;22(5):559–564. doi: 10.1111/j.1365-2125.1986.tb02935.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bergqvist Y., Hed C., Funding L., Suther A. Determination of chloroquine and its metabolites in urine: a field method based on ion-pair extraction. Bull World Health Organ. 1985;63(5):893–898. [PMC free article] [PubMed] [Google Scholar]
  3. Churchill F. C., Mount D. L., Patchen L. C., Björkman A. Isolation, characterization and standardization of a major metabolite of amodiaquine by chromatographic and spectroscopic methods. J Chromatogr. 1986 Apr 25;377:307–318. doi: 10.1016/s0378-4347(00)80786-0. [DOI] [PubMed] [Google Scholar]
  4. Churchill F. C., Patchen L. C., Campbell C. C., Schwartz I. K., Nguyen-Dinh P., Dickinson C. M. Amodiaquine as a prodrug: importance of metabolite(s) in the antimalarial effect of amodiaquine in humans. Life Sci. 1985 Jan 7;36(1):53–62. doi: 10.1016/0024-3205(85)90285-1. [DOI] [PubMed] [Google Scholar]
  5. Coleman M. D., Edwards G., Braithwaite I. M., Breckenridge A. M. High-performance liquid chromatographic method for the determination of amopyroquine in biological fluids. J Chromatogr. 1987 Feb 20;414(1):242–247. doi: 10.1016/0378-4347(87)80048-8. [DOI] [PubMed] [Google Scholar]
  6. Frisk-Holmberg M., Bergqvist Y., Termond E., Domeij-Nyberg B. The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects. Eur J Clin Pharmacol. 1984;26(4):521–530. doi: 10.1007/BF00542151. [DOI] [PubMed] [Google Scholar]
  7. Gustafsson L. L., Walker O., Alván G., Beermann B., Estevez F., Gleisner L., Lindström B., Sjöqvist F. Disposition of chloroquine in man after single intravenous and oral doses. Br J Clin Pharmacol. 1983 Apr;15(4):471–479. doi: 10.1111/j.1365-2125.1983.tb01532.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. HOEKENGA M. T. Intramuscular amopyroquin for acute malaria. Am J Trop Med Hyg. 1962 Jan;11:1–5. doi: 10.4269/ajtmh.1962.11.1. [DOI] [PubMed] [Google Scholar]
  9. HOEKENGA M. T. Propoquin in treatment of malaria. Am J Trop Med Hyg. 1957 Nov;6(6):987–989. doi: 10.4269/ajtmh.1957.6.987. [DOI] [PubMed] [Google Scholar]
  10. Le Bras J., Andrieu B., Hatin I., Savel J., Coulaud J. P. Plasmodium falciparum: interprétation du semi-microtest de chimiosensibilité in vitro par incorporation de 3H-hypoxanthine. Pathol Biol (Paris) 1984 May;32(5):463–466. [PubMed] [Google Scholar]
  11. Pussard E., Clavier F., Verdier F. Liquid chromatographic determination of amopyroquine in rabbit plasma and red blood cells. J Chromatogr. 1987 Oct 9;421(1):192–197. doi: 10.1016/0378-4347(87)80397-3. [DOI] [PubMed] [Google Scholar]
  12. Pussard E., Verdier F., Blayo M. C., Pocidalo J. J. Biotransformation de l'amodiaquine et prophylaxie du paludisme à Plasmodium falciparum. C R Acad Sci III. 1985;301(8):383–385. [PubMed] [Google Scholar]
  13. Pussard E., Verdier F., Faurisson F., Clavier F., Simon F., Gaudebout C. Disposition of amopyroquin in rats and rabbits and in vitro activity against Plasmodium falciparum. Antimicrob Agents Chemother. 1988 Apr;32(4):568–572. doi: 10.1128/aac.32.4.568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Pussard E., Verdier F., Faurisson F., Scherrmann J. M., Le Bras J., Blayo M. C. Disposition of monodesethylamodiaquine after a single oral dose of amodiaquine and three regimens for prophylaxis against Plasmodium falciparum malaria. Eur J Clin Pharmacol. 1987;33(4):409–414. doi: 10.1007/BF00637639. [DOI] [PubMed] [Google Scholar]
  15. Verdier F., Le Bras J., Clavier F., Hatin I. Blood levels and in vitro activity of desethylchloroquine against Plasmodium falciparum. Lancet. 1984 May 26;1(8387):1186–1187. doi: 10.1016/s0140-6736(84)91436-3. [DOI] [PubMed] [Google Scholar]
  16. Walker O., Salako L. A., Alván G., Ericsson O., Sjöqvist F. The disposition of chloroquine in healthy Nigerians after single intravenous and oral doses. Br J Clin Pharmacol. 1987 Mar;23(3):295–301. doi: 10.1111/j.1365-2125.1987.tb03048.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. White N. J. Drug treatment and prevention of malaria. Eur J Clin Pharmacol. 1988;34(1):1–14. doi: 10.1007/BF01061409. [DOI] [PubMed] [Google Scholar]
  18. White N. J., Looareesuwan S., Edwards G., Phillips R. E., Karbwang J., Nicholl D. D., Bunch C., Warrell D. A. Pharmacokinetics of intravenous amodiaquine. Br J Clin Pharmacol. 1987 Feb;23(2):127–135. doi: 10.1111/j.1365-2125.1987.tb03020.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Winstanley P. A., Edwards G., Orme M. L., Breckenridge A. M. Effect of dose size on amodiaquine pharmacokinetics after oral administration. Eur J Clin Pharmacol. 1987;33(3):331–333. doi: 10.1007/BF00637573. [DOI] [PubMed] [Google Scholar]
  20. Winstanley P., Edwards G., Orme M., Breckenridge A. The disposition of amodiaquine in man after oral administration. Br J Clin Pharmacol. 1987 Jan;23(1):1–7. doi: 10.1111/j.1365-2125.1987.tb03002.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES